These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 3113723

  • 21. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T, Okada M, Kishimoto S, Yamamura Y.
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
    Fidler IJ, Bucana C.
    Cancer Res; 1977 Nov; 37(11):3945-56. PubMed ID: 908034
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H, Fukuzawa M, Yoshioka T, Nakajima H, Hamaoka T.
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [Abstract] [Full Text] [Related]

  • 28. A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors.
    Van Loveren H, Den Otter W, Meade R, Terheggen PM, Askenase PW.
    J Immunol; 1985 Feb; 134(2):1292-9. PubMed ID: 3871209
    [Abstract] [Full Text] [Related]

  • 29. Mechanism of loss of natural killer activity in P815 ascites tumor bearing DBA/2 mice.
    Saxena RK, Saxena QB, Adler WH.
    Nat Immun Cell Growth Regul; 1985 Feb; 3(1):34-42. PubMed ID: 6235448
    [Abstract] [Full Text] [Related]

  • 30. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
    Hines DL.
    Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
    [Abstract] [Full Text] [Related]

  • 31. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
    Fernandez-Cruz E, Ulich T, Schreiber RD.
    J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
    [Abstract] [Full Text] [Related]

  • 32. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI, Taraban VY, Seledtsova GV, Samarin DM, Avdeev IV, Senyukov VV, Kozlov VA.
    Cell Immunol; 1997 Nov 25; 182(1):12-9. PubMed ID: 9427805
    [Abstract] [Full Text] [Related]

  • 33. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L.
    Cancer Res; 2002 Mar 15; 62(6):1884-9. PubMed ID: 11912169
    [Abstract] [Full Text] [Related]

  • 34. Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice.
    Schmitz J, Reali E, Hodge JW, Patel A, Davis G, Schlom J, Greiner JW.
    Cancer Res; 2002 Sep 01; 62(17):5058-64. PubMed ID: 12208761
    [Abstract] [Full Text] [Related]

  • 35. Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors.
    Liu B, Podack ER, Allison JP, Malek TR.
    J Immunol; 1996 Feb 01; 156(3):1117-25. PubMed ID: 8557987
    [Abstract] [Full Text] [Related]

  • 36. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA, Shu S, Chou T, Perry-Lalley D, Chang AE.
    J Immunol; 1988 Aug 01; 141(3):1047-53. PubMed ID: 3260908
    [Abstract] [Full Text] [Related]

  • 37. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J, Saffold S, Cao X, Krauss J, Chen W.
    J Immunol; 1998 Nov 15; 161(10):5516-24. PubMed ID: 9820528
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Effects of humoral factors of the mastocytoma P815 cells on the formation of allospecific killers in mixed culture of lymphocytes and their cytotoxic activity].
    Medvedev AE, Dostman U, Flegel' A.
    Biull Eksp Biol Med; 1989 Aug 15; 108(8):224-6. PubMed ID: 2529921
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.